Stem cell mobilization and diabetic skin ulcers
Stem cell mobilization and diabetic skin ulcers
批准号:
8370929
负责人:
David Margolis
金额:
$76.73万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2013-08-31
关键词:
AcuteAddressAgreementAmputationAnimalsAreaBiochemicalBiopsyBlood specimenCaringCell CountCell physiologyCellsCellular biologyCharacteristicsClinicClinicalClinical ResearchClinical ServicesCohort StudiesCommunitiesDataDebridementDiabetes MellitusDiabetic Foot UlcerDiseaseDistalDocumentationEthicsEventFoot UlcerGoalsHealedHematopoietic Stem Cell MobilizationHomingHyperbaric OxygenHypoxia Inducible FactorImpairmentInstitutesInstitutional Review BoardsInterventionLimb structureLower ExtremityManualsMarylandMeasurementMetabolicMethodsNeuropathyNew YorkOhioPatientsPersonsPharmaceutical PreparationsPopulation StudyProceduresProcessProteinsPublicationsPublishingRecruitment ActivityRefractoryRemunerationsResearchRiskSecureSiteSkin UlcerStem cellsSterile coveringsTechniquesTissue SampleTissuesTreatment ProtocolsUlcerVariantWorkWound Healingbasecommunity based treatmentdiabeticdiabetic patientdiabetic wound healingeffective therapygenetic regulatory proteinhealingimprovedinsightneovascularizationpatient populationresponsestandard carestemsuccesstooltreatment planningwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Management of lower extremity neuropathic ulcers in diabetic patients has changed little in the past decade. The healing rate is poor, risk of amputations relatively high, and there is a paucity of objective methods for choosing treatments. We will carry out a multi-center clinical cohort study of circulating and wound margin vasculogenic stem/progenitor cells (SPCs) in diabetic patients undergoing treatment for lower extremity neuropathic ulcers. The goal is to develop simple, quantitative methods that provide guidance on effective treatment choices. Our hypothesis is that an analysis of SPCs number and their biochemical characteristics can predict whether diabetic foot ulcers will heal. The experimental approach is built on the very productive framework used in our preliminary R21 project and recent publication. The four specific aims center on SPCs and their association with traditional methods for assessing diabetic control and wound characteristics. Aims are as follows: (1) Determine whether SPCs mobilization/wound recruitment and hypoxia inducible factor-related processes are associated with wound repair, (2) Assess if wound care practices are associated with SPCs mobilization and SPCs homing to wounds, (3) Determine if variations in SPCs are associated with healing, and (4) Assess whether SPCs differences observed between a healing acute biopsy wound versus the foot ulcer are related to clinical issues such as metabolic status. We will evaluate whether SPCs number and content of several intracellular proteins correlate with wound and disease-related factors and whether these measurements can be used to predict diabetic wound healing.
PUBLIC HEALTH RELEVANCE: We plan to carry out a multi-center clinical cohort study of circulating and wound margin vasculogenic stem/progenitor cells in diabetic patients undergoing treatment for limb-threatening lower extremity neuropathic ulcers. The goal is to develop simple, quantitative methods to assess ulcers that provide guidance on effective treatment choices. Our hypothesis is that an analysis of stem/progenitor cell number and their biochemical characteristics can predict whether diabetic foot ulcers will heal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
-
批准号:10296086
-
项目类别:
-
资助金额:$104.05万
-
财政年份:2021
-
负责人:David Margolis
-
依托单位:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
-
批准号:10470869
-
项目类别:
-
资助金额:$102.93万
-
财政年份:2021
-
负责人:David Margolis
-
依托单位:
Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women
-
批准号:9815052
-
项目类别:
-
资助金额:$24.95万
-
财政年份:2019
-
负责人:David Margolis
-
依托单位:
NOS1AP and Capon Associated Impaired Healing in Those with Diabetic Foot Ulcers
-
批准号:9925084
-
项目类别:
-
资助金额:$60.51万
-
财政年份:2018
-
负责人:David Margolis
-
依托单位:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
-
批准号:9228322
-
项目类别:
-
资助金额:$55.13万
-
财政年份:2016
-
负责人:David Margolis
-
依托单位:
Data Sciences and Informatics
-
批准号:10477235
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2016
-
负责人:David Margolis
-
依托单位:
African-Americans with Atopic Dermatitis: Skin Barrier and Immune
-
批准号:9868281
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2016
-
负责人:David Margolis
-
依托单位:
Data Sciences and Informatics
-
批准号:10663986
-
项目类别:
-
资助金额:$23.37万
-
财政年份:2016
-
负责人:David Margolis
-
依托单位:
Stem cell mobilization and diabetic skin ulcers
-
批准号:8538377
-
项目类别:
-
资助金额:$58.57万
-
财政年份:2012
-
负责人:David Margolis
-
依托单位:
Stem cell mobilization and diabetic skin ulcers
-
批准号:8731122
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2012
-
负责人:David Margolis
-
依托单位:
Stem cell mobilization and diabetic skin ulcers
-
批准号:9122402
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2012
-
负责人:David Margolis
-
依托单位:
Comparative Effectiveness of Adjunctive Devices For the Previous
-
批准号:8230818
-
项目类别:
-
资助金额:$36.27万
-
财政年份:2011
-
负责人:David Margolis
-
依托单位:
Comparative Effectiveness of Adjunctive Devices For the Previous
-
批准号:8108418
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2011
-
负责人:David Margolis
-
依托单位:
Comparative Effectiveness of Adjunctive Devices For the Previous
-
批准号:8447992
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2011
-
负责人:David Margolis
-
依托单位:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
-
批准号:8321208
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2009
-
负责人:David Margolis
-
依托单位:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
-
批准号:7808038
-
项目类别:
-
资助金额:$54.74万
-
财政年份:2009
-
负责人:David Margolis
-
依托单位:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
-
批准号:8040004
-
项目类别:
-
资助金额:$50.71万
-
财政年份:2009
-
负责人:David Margolis
-
依托单位:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
-
批准号:8242639
-
项目类别:
-
资助金额:$29.75万
-
财政年份:2009
-
负责人:David Margolis
-
依托单位:
Filaggrin Mutations and the Prognosis of Atopic Dermatitis
-
批准号:7565094
-
项目类别:
-
资助金额:$54.81万
-
财政年份:2009
-
负责人:David Margolis
-
依托单位:
Acne and group A strep: an unknown burden
-
批准号:6864401
-
项目类别:
-
资助金额:$58.0万
-
财政年份:2005
-
负责人:David Margolis
-
依托单位:
海外基金